logo

Calithera Biosciences Inc. (CALA)



Trade CALA now with
  Date
  Headline
6/4/2018 8:18:11 AM Calithera Biosciences Announces Clinical Data From Lead Product Candidate CB-839
4/18/2018 7:05:19 AM Calithera Biosciences Announces FDA Fast Track Designation Granted To CB-839 In Combination With Cabozantinib
10/5/2017 7:37:55 AM William Blair Initiates Calithera Biosciences Inc. (CALA) At Outperform
1/24/2017 10:01:12 AM Citigroup Ups Calithera Biosciences Inc. (CALA) To neutral From sell With -- Price Target